Privi Speciality Chemicals Shareholders Approve Scheme of Amalgamation
Privi Speciality Chemicals Ltd 路 Court Convened Meeting 路 28 Oct 2026, 12:11 am
Privi Speciality Chemicals Shareholders Approve Scheme of Amalgamation Privi Speciality Chemicals Limited announced that its equity shareholders approved the Scheme of Amalgamation with Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited during an NCLT-convened meeting held on 27th Oct'26. The resolution passed with an 89.72% overall majority (2,66,47,091 votes in favor vs. 30,53,788 against). Among public equity shareholders, the scheme secured 60.95% approval (47,66,837 votes in favor vs. 39.05% against), satisfying the required statutory and regulatory majority thresholds under the Companies Act and SEBI regulations.
Original exchange filing (PDF)
More announcements from Privi Speciality Chemicals Ltd
- Announcement under Reg 30 - Transcript of Q2 Earnings Call held on October 30, 2026. 路 03 Nov 2026
- Outcome of Earnings Call held on 30.10.2026 @ 04:00 pm - Audio Link 路 31 Oct 2026
- Investor Presentation - Financial & Operational Review for Quarter and half year ended September 30,2026. 路 30 Oct 2026
- Outcome of Board Meeting held on October 29.10.2026 to consider and approve Financial Results of Q2 FY27, declaration of Interim Dividned and Proposed investment in Solar Power Project. 路 29 Oct 2026
- Outcome of Board Meeti ng - Approving Record Date for the purpose of Interim Dividend 路 29 Oct 2026
- Outcome of Board Meeting - Approval of 1st Interim Dividned FY 2026-27 路 29 Oct 2026
- Outcome of Board Meeting - Financial Results for quarter and half year ended September 30, 2026 路 29 Oct 2026
- Privi Speciality Chemicals Limited has submitted to the Exchange, the outcome of the Board Meeting held on October 29,2026. 路 29 Oct 2026
